Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modeling longitudinal data in acute illness.

Gilles Clermont

    Critical Care (London, England)
    |August 11, 2007
    PubMed
    Summary
    This summary is machine-generated.

    Biomarkers for sepsis enable early identification of high-risk patients for life-saving interventions. Advanced modeling of biomarker profiles is crucial for personalized immunomodulatory therapies and clinical trial design.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cardiovascular and Autonomic Phenotypes Reveal Distinct Mechanisms of Sepsis Decompensation via Deep Learning.

    Research square·2026
    Same author

    A comprehensive cross-sectional study of bedside monitor alarm characteristics and alarm load across hospital units.

    Scientific reports·2026
    Same author

    Development and evaluation of a prediction model for adult ICU hemorrhage using only continuous cardiorespiratory data.

    Physiological measurement·2026
    Same author

    How much information is needed to predict outcomes after cardiac arrest?

    Resuscitation·2025
    Same author

    Adversarial Debiasing for Equitable and Fair Detection of Acute Coronary Syndrome Using 12-Lead ECG.

    IEEE transactions on bio-medical engineering·2025
    Same author

    A Machine Learning Trauma Triage Model for Critical Care Transport.

    JAMA network open·2025
    Same journal

    Comparative performance of mitral E/e' versus inferior vena cava variability for predicting fluid responsiveness in mechanically ventilated adults with shock.

    Critical care (London, England)·2026
    Same journal

    Different lungs or different patients? Insights into postoperative ARDS.

    Critical care (London, England)·2026
    Same journal

    Predictive validity of SOFA-2: analytical and contextual considerations.

    Critical care (London, England)·2026
    Same journal

    Interpreting elevated FRAP in critical illness: beyond antioxidant capacity.

    Critical care (London, England)·2026
    Same journal

    Cytokine-based strategies to improve prognostic enrichment of pediatric ARDS.

    Critical care (London, England)·2026
    Same journal

    Genomic dynamics of antimicrobial resistance transmission between bacteria from intensive care unit surfaces and from critically ill patients.

    Critical care (London, England)·2026
    See all related articles

    Area of Science:

    • Critical care medicine
    • Biostatistics
    • Computational biology

    Background:

    • Sepsis biomarker discovery is key for early risk stratification.
    • Immunomodulatory therapies offer potential life-saving interventions for sepsis.
    • Personalized treatment requires understanding longitudinal biomarker profiles.

    Discussion:

    • Advanced modeling techniques are essential for interpreting complex biomarker data.
    • Longitudinal biomarker profiles need to be analyzed in relation to patient characteristics, disease progression, and treatment.
    • Developing patient-specific models is crucial for optimizing immunomodulatory therapies.

    Key Insights:

    • Biomarker-driven, individualized interventions can improve sepsis outcomes.
    • Sophisticated statistical and mathematical models are needed for biomarker profile analysis.

    Related Experiment Videos

  • Critical illness settings are ideal for applying and validating these emerging modeling techniques.
  • Outlook:

    • Validated models can guide rational clinical trial design and interpretation.
    • Point-of-care testing enhances the feasibility of real-time biomarker monitoring.
    • Emerging modeling techniques promise to revolutionize critical care and personalized medicine.